35.4 C
Vientiane
Thursday, April 24, 2025
spot_img
Home Blog Page 126

Natra Bintan Unveiling ‘Bintan Island Escape’ Package

BINTAN ISLAND, Indonesia, April 11, 2025 /PRNewswire/ — Tucked away on the picturesque island of Bintan, Indonesia, Natra Bintan, a Tribute Portfolio Resort, is a hidden gem that offers a luxurious glamping experience like no other. This stunning resort is nestled amidst a lush tropical landscape, overlooking the largest Crystal Lagoon in South East Asia. With its unique blend of luxury and nature, Natra Bintan is the perfect destination for those seeking a tranquil and indulgent Bintan island getaway.

Natra Bintan, a Tribute Portfolio Resort
Natra Bintan, a Tribute Portfolio Resort

Located in the same complex, Treasure Bay Bintan is a tropical playground waiting to be explored. Guest can do ATV off-road adventure or enjoy a thrilling water sports activities like kayaking, slip & slide, cable tube and wakeboarding, or just doing relaxing activities like paddle boats, floats, bicycle, e-scooter & mangrove tour, there’s something for everyone to enjoy.

For those seeking a more immersive cultural experience, Bintan Island offers a wealth of opportunities to explore its rich history and heritage. Visit Ksitigarbha Bodhisattva Temple, which is famous for its 500 life-sized lohan statues and explore Senggarang Village which known to be the first settlement of the ethnic Chinese in Bintan. Here, you will find the centuries-old Banyan Tree Temple and the historically rich Lau Ya Keng temple or simply experience the vibrant local markets and cuisine.

In this upcoming school holiday season in June, Natra Bintan is excited to unveil Bintan Island Escape package, designed to provide families & guests with an unforgettable Bintan getaway experience. This package includes luxurious glamping accommodations, daily breakfast, 1x set menu dinner, 1x sunset drink & 1x hour traditional massage for 2 persons and additionally guest could enjoy the complimentary daily activities such as bicycle tour to explore Lagoi Beach, traditional dancing class, art & craft classes and photo services assisted by our talent to capture the perfect photo memories. With a minimum stay of three days and two nights, guests can indulge in this ultimate island retreat.

Plan your next holiday at Natra Bintan and create unforgettable memories with your loved ones. Whether you’re celebrating a special occasion or simply seeking a relaxing getaway, the glamping resort offers the perfect setting. Book your stay at www.marriott.com/tnjtx or download Marriott Bonvoy Apps to reserve the experience of the ultimate glamping getaway.

***

About the Natra Bintan, a Tribute Portfolio Resort.  Natra Bintan, a Tribute Portfolio Resort, Bintan is located in the most prestigious district tourism area of Bintan,Riau. Jalan Raya Haji Km 01 Kawasan Pariwisata, Sebong Lagoi, Bintan Island, Riau Islands 29152.  The glamorous camping resort comprises 100 of tents, 2 restaurant, and 208 sqm of meeting rooms. A member of Marriott International’s Tribute Portfolio, guests of Natra Bintan can take advantage of all the perks of the Marriott Bonvoy global travel program and earn and redeem points during their stays. Marriott Bonvoy members can enjoy exclusive benefits, such as complimentary welcome drink, room upgrade and many more. More information can be found at www.marriott.com/tnjtx and by following the property on Facebook and Instagram.

About Marriott Bonvoy® Marriott Bonvoy, Marriott International’s portfolio of more than 30 hotel brands and 10,000 global destinations, offers renowned hospitality in the most memorable locations around the world. The award-winning travel program and marketplace gives members access to transformative, eye-opening experiences around the corner and across the globe. To enroll for free or for more information about Marriott Bonvoy, visit marriottbonvoy.com. To download the Marriott app, go here. Travelers can also connect with Marriott Bonvoy on Facebook, X, Instagram, and TikTok.

H&S Unveils Characteristic Wellness Innovations at FHA 2025 Singapore


SINGAPORE – Media OutReach Newswire – 11 April 2025 – H&S (the “Company”), a leading Australian wellness company, proudly showcased its exceptional portfolio of brands at FHA-Food & Beverage 2025 (“FHA 2025”), Asia’s premier food and hospitality trade show, held from April 8 to 11 in Singapore. H&S leveraged this platform to connect with industry leaders, distributors, and consumers, further solidifying its presence in the global wellness market.

H&S’s flagship products exemplify the Company’s state-of-the-art innovations in health and wellness.
H&S’s flagship products exemplify the Company’s state-of-the-art innovations in health and wellness.

H&S: A Global Wellness Pioneer
Since its establishment in 2009, H&S has emerged as a global pioneer in the wellness industry, delivering premium health solutions to over 50 million consumers across more than 20 countries. At FHA 2025, H&S presented eight flagship brands—Oli6, Brauer, BTNature, Rapid Loss, DOBO, Nutrition29, Moroka, and TEMIO—each representing the Company’s commitment to excellence and innovation, making wellness accessible and effortless for individuals worldwide.

Innovation in Wellness: Spotlight on Three
Flagship Brands

BTNature: Science-Backed Dairy Nutrition

BTNature has captured attention with its dedication to premium dairy nutrition. Sourcing milk exclusively from Australia and New Zealand, where cows graze on nutrient-rich Green Gold” ryegrass, BTNature ensures exceptional purity and quality. The brand leverages its patented medium heat powder spraying technology, precisely controlling drying and dusting temperatures. This process preserves the natural nutrients and fresh milk flavor, making BTNature’s products highly competitive in global markets. Its standout product, BTNature Premium Full Cream Instant Milk Powder, received the prestigious 3-star award—the highest accolade—at the 2024 Superior Taste Awards and was honored as a Best Dairy Product Finalist at the World Food Innovation Awards 2025.

To highlight its versatility, BTNature demonstrated innovative use of its milk powder at FHA 2025—preparing snowflake nougat, inspiring business buyers with creative culinary applications.

Brauer: Gentle and Effective Health Solutions

With over 90 years of heritage, Brauer has become a trusted brand among Australian families, offering gentle yet highly effective health solutions. Best known for its Kids Vitamins, Brauer integrates natural medicine and potent herbal ingredients to create products loved by parents.

Brauer Sambucus Little Sniffles, one of Brauer’s signature products, features Sambucus nigra (elderberry), a herb renowned for boosting immunity and alleviating cold and cough symptoms in children as young as six months and older. Its proven effectiveness and widespread acclaim earned it The Consumer Good of the Year (Vitamins & Supplements) award at the FMCG Asia Awards 2024.

Mr. Louie Coorey (left), General Manager, Asia Pacific Region at H&S, with Ms. Pragase Komargan (right), Austrade Representative, during FHA 2025 Singapore.
Mr. Louie Coorey (left), General Manager, Asia Pacific Region at H&S, with Ms. Pragase Komargan (right), Austrade Representative, during FHA 2025 Singapore.


Moroka: Immunity Support for All Ages

Moroka has positioned itself at the forefront of immunity-boosting nutrition, responding to the growing consumer demand for Lactoferrin-enriched products. Its formulations are packed with essential nutrients such as Immunoglobulin G (IgG), lactoferrin, vitamins, and minerals—designed to support overall immune, respiratory, and digestive health for individuals of all ages. The brand’s latest innovation, Moroka Immunity Knight Formulated Milk Powder with Lactoferrin, won the Best Functional Product award at the World Food Innovation Awards 2025. Manufactured in a TGA-certified facility under HACCP and HALAL standards, Moroka continues to deliver scientifically advanced solutions that align with evolving wellness needs.

Driving Innovation Through Market Insights

H&S’s commitment to wellness is deeply rooted in understanding consumer trends. As health-conscious individuals actively seek products that blend efficacy with natural ingredients, the Group has continuously strengthened its research capabilities. By embracing scientifically validated formulations, prioritizing sustainability, and enhancing convenience, H&S ensures its products fulfill the needs of modern consumers.

At FHA 2025, H&S engaged attendees with interactive product demonstrations, tastings, and expert discussions, highlighting the unique benefits of its flagship offerings. This milestone event not only amplified H&S’s global presence but also set the stage for future collaborations, reinforcing its philosophy that “Happiness Can Be Simple”—making wellness more accessible to all.

H&S also delved into strategic discussions with Austrade during the exhibition, focusing on emerging wellness trends and exploring partnership opportunities across Singapore and Southeast Asia. This dialogue underscores H&S’s commitment to continuously expanding its regional presence while addressing the ever-evolving demand for integrated health and wellbeing solutions.

From left to right: Mr. Louie Coorey, General Manager of the Asia Pacific Region at H&S; Ms. Irene Tay, Business Development Director of Austrade Singapore; Mr. Christopher Morley, Australian Trade and Investment Commissioner; Mr. Jason Zhang, Export Business Development Manager at H&S.
From left to right: Mr. Louie Coorey, General Manager of the Asia Pacific Region at H&S; Ms. Irene Tay, Business Development Director of Austrade Singapore; Mr. Christopher Morley, Australian Trade and Investment Commissioner; Mr. Jason Zhang, Export Business Development Manager at H&S.
H&S staff present the Company’s leading wellness products to business partners at FHA 2025 Singapore.
H&S staff present the Company’s leading wellness products to business partners at FHA 2025 Singapore.


Looking Ahead

H&S remains committed to sustainable growth, channelling investments into research and development to expand its premium health and nutrition portfolio. Through a focus on ethical sourcing and cutting-edge innovation, the Company is poised to deliver superior wellness solutions to an even broader audience worldwide.

Business Development Contact:
Mr. Louie Coorey – General Manager of the Asia-Pacific Region at H&S
Mobile: +61401984566
Email: lou.c@hsglobal.com.au

Hashtag: #H&S #FHA2025




The issuer is solely responsible for the content of this announcement.

About H&S

Established in Australia, H&S is a globally recognized leader in health and wellness, dedicated to enhancing lives through premium and innovative products. With a presence in over 20 countries, H&S serves more than 50 million consumers worldwide through its network of 300+ international brands, 150+ online stores, and 2,000+ retail locations. Operating across three core sectors—Brands, E-commerce, and Investments—H&S is at the forefront of wellness innovation, driven by a commitment to quality and sustainability.

To learn more about H&S and its portfolio, visit .

Back From Extinction: Meet the Baby ‘Dire Wolves’ Stirring Science, Social Media

This undated and unlocated handout image courtesy of Colossal Biosciences shows Colossal's "dire wolf" pups Romulus and Remus at 15 days old. This week, Texas-based start-up Colossal pulled off a major publicity stunt by releasing images of what it describes as “canis dirus”, giant North American wolves that disappeared over 12,000 years ago. (Photo by Colossal Biosciences / AFP)

By Charlotte CAUSIT/AFP – They whimper, drink from baby bottles and crawl oh so tentatively. They look like cute white puppies, not the fruit of a daring project to resuscitate an extinct species.

A Texas startup called Colossal Biosciences made a big splash this week by releasing footage of canines they say are dire wolves, a species that vanished more than 12,000 years ago.

“For the first time in human history, Colossal successfully restored a once-eradicated species through the science of de-extinction,” the company states on its website.

Photos and video of these critters have flooded social media and shaken the scientific community, which has reacted with a mix of enthusiasm and skepticism over this experiment reminiscent of “Jurassic Park” — the fictional story of a quirky rich man’s attempt to bring back the dinosaurs.

The company says it did it by tweaking the DNA of a modern-day gray wolf with carefully chosen genes from dire wolf fossils. This modified genetic material was then inserted in a grey wolf egg and implanted in a common dog as a surrogate mom.

The result: three baby dire wolves, Colossal Biosciences claims.

“I think the claims are vastly overblown,” Alan Cooper, an evolutionary molecular biologist who took part in a previous study of dire wolf DNA, told AFP.

“It would be like me putting a couple of genes into you from Neanderthals that made you extra hairy and grow more muscles, and then called you a Neanderthal,” said Cooper.

“That’s a million miles from Neanderthal. It’s a hairy human.”

“This is not the dire wolf. This is something they have created that has phenotypic characteristics of dire wolf,” said Lisette Waits, an ecologist and professor of wildlife resources at the University of Idaho.

Waits, who has worked extensively on grey wolf genetics and red wolf conservation issues, nonetheless called this achievement a breakthrough.

The pups are named Romulus and Remus, in a nod to the twin brothers of Roman mythology, and Khaleesi, of “Game of Thrones” fame.

Debate

The Colossal Biosciences team studied DNA from two dire wolf fossils  — a tooth from 13,000 years ago and a skull fragment dated back 72,000 years — and compared them to the DNA of the gray wolf, a species that is alive and well.

This undated and unlocated handout image released courtesy of Colossal Biosciences shows Colossal’s “dire wolves” Romulus and Remus at five months old. This week, Texas-based start-up Colossal pulled off a major publicity stunt by releasing images of what it describes as “canis dirus”, giant North American wolves that disappeared over 12,000 years ago. (Photo by Colossal Biosciences / AFP)

The team concluded these two kinds of DNA are around 99.5 percent identical, Beth Shapiro, the company’s chief science officer, told AFP.

An analysis of the differences between the two kinds of DNA determined which genes could be responsible for the dire wolf’s size, muscle structure and its white fur.

With this information the team modified blood cells from a grey wolf by inserting some of those dire wolf genes. A total of 20 changes were made using the genetic manipulation technique known as Crispr-Cas 9, which is also used in human genetics.

The blood cells were then transferred to a gray wolf egg cell that was implanted in a dog. The results: Romulus, Remus and Khaleesi.

Whether these animals are actual dire wolves or simply genetically modified gray wolves, Shapiro insisted, “is a semantic, philosophical argument.”

She added that it will never be possible to create an animal that is 100 percent genetically identical to a species that is extinct.

“But neither is that the goal. Our goal is to create functional equivalents of those species,” the scientist said.

Dodos and Wooly Mammoths

The company plans to apply this technique to dodo birds and woolly mammoths.

Just last month it released photos of mice injected with genetic material from one of those extinct pachyderms, yielding controversy and some very furry rodents.

Some scientists say the goal of recreating extinct species is unattainable and even dangerous. But others welcome it as an ambitious way to fight the planet’s steady loss of biodiversity.

Waits, the conservation specialist, said that aside from the hoopla over this experiment this technique could help endangered species recover.

Colossal Biosciences has managed to lure more than USD 200 million in investment money, which would be a very tall task for other conservation causes, she added.

Ronald Sandler, a professor of philosophy and ethics at Northeastern University, said he worries this technique might lead to “moral distraction” away from the causes of animals going extinct, like climate change and habitat loss.


© Agence France-Presse

Futu Secures Six Consecutive Years of HKEX Awards Leading in Futures, Options, and Currency Futures Trading Volumes Among Retail Brokers

HONG KONG, April 11, 2025 /PRNewswire/ — Futu Holdings Limited (Nasdaq: FUTU)(“Futu” or the “Company”), a leading tech-driven digitalized brokerage and wealth management platform, is pleased to announce its subsidiaries have garnered six prestigious honours at the Hong Kong Exchange and Clearing Limited (HKEX) Awards. These accolades recognize Futu’s active trading in options and futures, currency futures, and Exchange-Traded Products(ETP), as well as the company’s position as a go-to platform for derivative data and diversified investment product trading.

Futu has been honoured "Top Retail Broker" at HKEX Awards
Futu has been honoured “Top Retail Broker” at HKEX Awards

 

Six Consecutive Years of Award-Winning Excellence reflects Futu’s achievements
Six Consecutive Years of Award-Winning Excellence reflects Futu’s achievements

Six Consecutive Years of Award-Winning Excellence reflects Futu’s achievements

This year marks Futu’s sixth consecutive year of winning these awards. Futu has been honored with six major awards: “Exchange Traded Products  – Top Breakthrough Broker”, “Top Exchange Participant – Weekly Stock Options”, “Top Retail Broker”, “Top Broker – Currency Futures” , “Top Derivatives Clearing Member” and “Enterprise Data Package Data Vendor”. These awards reflect Futu’s highest total trading volume among Hong Kong retail brokers in various futures and options, as well as currency futures categories. Futu also excelled in growing non-broker activity turnover in Exchange Traded Products and derivative data subscription fees, surpassing other participants and data providers in these areas.

As a leading Tech Brokerage in Hong Kong, Futu Securities is committed serves million of local investors and is trusted by a wide range of investors. Futu has reached a significant milestone, with 1 in every 2 adults trusting Futu to power their investment journey. In addition, Futu has recently launched new artificial intelligence (AI)-powered tools on the company’s investment app Futubull, reinforcing Futu’s commitment to continuously leveraging cutting-edge technologies to empower retail investors.

Mr. Daniel Tse, Managing Director of Futu Securities, said: “The HKEX awards recognize financial institutions that make a positive contribution to the local trading market. Despite last year’s global market volatility and various uncertainties affecting investor sentiment, Futu has gained trust of numberous of investors through its exceptional user experience and functional advantages. Winning the HKEX Awards for the sixth consecutive year, further validates the HKEX’s recognition regarding the diversity and accessibility of Futu’s products, as well as its prominent position in ETP, derivative product investments and data provision. Moving forward, Futu will continue to enhance the diversity and flexibility of its trading categories to meet investors’ needs. Futu is also dedicated to actively promoting investor education, aiming to a trusted partner for investors on their journey to wealth accumulation, thereby fostering the steady development of Hong Kong’s capital market.”

 

Thermo King Launches Flagship LEGEND Trailer Refrigeration Unit with Asian-based Production

SHANGHAI, April 11, 2025 /PRNewswire/ — Thermo King, a strategic brand of Trane Technologies (NYSE: TT), a global climate innovator, has announced the launch of its first Asian-made trailer refrigeration unit production line at the new smart plant in Wujiang, China. This production line is dedicated to the LEGEND series – the flagship products developed by Thermo King Asia Pacific. These units will be supplied to markets across Aian, marking a strategic milestone in Thermo King’s localization efforts in R&D and manufacturing.

TK Launches Flagship LEGEND Trailer Refrigeration Unit with  Asian-based Production
TK Launches Flagship LEGEND Trailer Refrigeration Unit with Asian-based Production

In line with the company’s Future Factory Initiative, the highly automated and intelligent new production line has increased the localization rate of the LEGEND supply chain by 60%, significantly shortened the delivery cycle, and greatly enhanced the stability and flexibility of the refrigeration equipment supply chain across the Asia Pacific region. This development propels the cold chain logistics industry towards a more efficient, intelligent and sustainable future.   

“The localized production of LEGEND products is a key milestone for Thermo King to deepen its presence in the Asia Pacific market.” said Helen Ling, vice president of Trane Technologies Asia Pacific, “We have achieved a breakthrough in the entire process of independently developed a product, from design to large-scale manufacturing. We also worked with local suppliers to create the industry-leading ‘three-in-one’ motor technology through a series of technical advancements. This accomplishment marks our completion of a full cycle from independent R&D to mass production. Moving forward, Thermo King will continue to invest in cutting-edge technologies and work with our partners to drive greater quality and efficiency in regional cold chain logistics. “

The new LEGEND series is built on Thermo King’s world-leading Trailer platforms, specially designed for high-frequency road transportation in Asia Pacific, combining three advantages – precise temperature control, efficient energy saving, and intelligent operation and maintenance. With its advanced electrical architecture and independent airflow control technology, it enables precise all-zone temperature management tailored to cargo types and transportation conditions. This ensures the consistency of temperature control throughout the transportation process, and delivering uniform temperature distribution even at low engine speed, which effectively avoids local temperature variations for high-value goods such as fresh food and medicine, and significantly reduces the cargo damage rate.

For high efficiency and energy saving, the LEGEND series adopts the breakthrough “three-in-one” motor technology, integrating the motor, permanent magnet generator, and active rectifier. Compared with the traditional mechanical drive solution, the LEGEND series uses 27% fewer components, saving installation space while improving the unit’s fuel efficiency by 15%. Simultaneously, with the coordinated operation of brushless fans, smart control algorithm and electronic engine speed control (ECO Governor), the unit can deliver up to 20% fuel efficiency in actual scenario. Besides, the LEGEND series can also achieve fast pull down and consistent capacity output across all conditions. Its ability to monitor engine load ensures reliable operation, cutting overall maintenance needs by 30% and reducing downtime losses by 52%.

In addition, the LEGEND series enjoys improved product reliability thanks to the intelligent operation and management system. It features an IP67 HMI with multi-language support, live fuel consumption data display, and automated Pretrip self-check function to avoid unexpected downtime. The standard Tbox telematics solution can continuously track the operating status of the unit, ensuring a fully controlled refrigeration transportation process.

The LEGEND series has ovtained the certification for China GB IV emission regulation. The first batch of products will be applied mainly in the inter-city highway refrigerated transport market, with planned expansion into railway applications and compliance with EU stage V emission regulation. In the future, Thermo King will continue the green manufacturing practice, driving the high-quality development of the Asia-Pacific refrigeration logistics industry through intelligent upgrades of production lines and R&D efforts on high-efficiency energy-saving technologies.

About Trane Technologies

Trane Technologies is a global climate innovator. Through our strategic brands Trane® and Thermo King®, and our portfolio of environmentally responsible products and services, we bring efficient and sustainable climate solutions to buildings, homes and transportation. For more on Trane Technologies, visit www.tranetechnologies.com.

About Thermo King

Thermo King – by Trane Technologies (NYSE: TT), a global climate innovator – is a worldwide leader in sustainable transport temperature control solutions. Thermo King has been providing transport temperature control solutions for a variety of applications, including trailers, truck bodies, buses, air, shipboard containers, and railway cars since 1938. For more information, visit www.tranetechnologies.cn or www.thermoking.com.cn.

 

Promote the landing of new quality productivity in the culture and tourism scene! Tourism Plus Shanghai 2025 ended successfully!

SHANGHAI, April 11, 2025 /PRNewswire/ — On April 3rd, Tourism Plus Shanghai 2025 was successfully ended! The expo is guided by Shanghai Municipal Administration of Culture and Tourism, co-sponsored by China Tourism Association, and hosted by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. and Shanghai International Convention & Exhibition Co., Ltd. With 5 collective exhibitions, 4 exhibition centers in Pudong and Puxi, and more than 6,000 exhibitors, the expo welcomed 445,737 visitors from 148 countries and regions during the 5-day exhibition period. Among them, the number of visitors from overseas reached a new high of 20,918, an increase of 32% compared to last year! The linkage effect of culture, tourism, commerce, sports and exhibitions brought by the exhibition is about 1 billion yuan or more.

From March 30 to April 3, Tourism Plus Shanghai 2025 was held at the National Exhibition and Convention Center (Shanghai), Shanghai World Expo Exhibition & Convention Center, Shanghai New International Expo Centre, and Shanghai Convention & Exhibition Center of International Sourcing. The five collective exhibitions include HOTELEX – Shanghai International Hospitality Equipment & Food service Expo, Tourism Plus Shanghai, China (Shanghai) International Boat Show & The Lifestyle Show Shanghai, Hotel & Shop Plus-Shanghai International Hotel, Shop, Office and Public Space Expo, Modern Concept World Expo, covering a total of 15 industrial categories and 68 exhibition sections.

Investment matchmaking meeting in 7 vertical fields held during the same period of the expo were included in the 2025 Shanghai Culture & Tourism Investment Promotion Week, providing more than 1,000 face-to-face investment discussions for both participants. At the same time, the expo also held 8 lifestyle festivals involving tourism quality life, water-sports and lure, coffee and wine, tea and drinks, trendy food, accommodation supplies, and art and visual display. 22 international and domestic competitions covered virtual sports events, lure fishing, coffee, tea and drinks, cooking, baking, desserts, hotel skills, hotel uniforms, cleaning and other aspects. More than 180 professional forums covered tourism innovation, new economy of global culture and tourism, immersive projects, creative Industry, customized tours, health industry, boat industry development, catering innovation, catering design, sustainable food design, tea and coffee industry linkage, hotel and catering intelligent system, catering ecological construction, catering supply chain innovation, chain franchise, Chinese food expanding overseas, Chinese solar term dishes, interior design, lighting design, office design, landscape design, BIM, retail innovation, outlets industry, business and cultural tourism scene innovation, hotel investment, hotel brand, hotel procurement, smart hotel, green hotel, e-sports hotel, service robot application, stock asset transformation, new quality habitat, business travel sleep, retail digitization, shopping center management, commercial asset AI management, smart property, property management innovation, cleaning, environmental sanitation, air cleaning, architectural shading, wedding industry and other professional fields. And over 100 roadshows, new product launches, product promotions, catwalk, awards ceremonies, dinners, and other events.

The platform effect of this expo is particularly significant in promoting the landing of new quality productivity in the culture, business and tourism scene. Many enterprises joined the expo, including robots, intelligent, new energy, green building materials and lighting enterprises, and low-altitude economy, and provided new quality productivity solutions for “catering, accommodation, transportation, visiting, shopping, and entertainment” full tourism and lifestyle scenarios.

At the level of industrial coordination, the expo fully promotes the deep integration of “industries + tourism”, and helps hotels, catering, retail, sports and other industries link with tourism, fostering new formats and building a new pattern of global tourism development.

Tens of thousands of new products radiating around the world have been launched, injecting a steady stream of fresh vitality into the tourism industry chain. The all-round linkage of culture, tourism, business, sports and exhibitions has amplified the spillover effect of the exhibition, stimulated the potential of tourism and surrounding industries consumption.

“United Sectors, Boundless Journeys”, as the expo slogan, Tourism Plus Shanghai unites more and more sectors year by year, and is one of the three major Shanghai tourism events yearly. Through continuous resource aggregation and ecological incubation, Tourism Plus Shanghai is actively shaping a broader blueprint for the tourism industry by creating an industry chain platform of “tourism + industries” and “industries + tourism”, becoming a key node of the global tourism industry innovation network, and helping Shanghai become the tourism investment gateway in Asia.

Let us meet again at Tourism Plus Shanghai 2026! See you March 29th to April 3rd, 2026.

CCV Capital’s Founding Managing Partner Wei Zhou Attends the 2025 Harvard College China Forum

CAMBRIDGE, Mass., April 11, 2025 /PRNewswire/ — From April 4th to April 6th, 2025 (Eastern Time), the 28th Harvard College China Forum was successfully held on the campus of Harvard University. Wei Zhou, Founding Managing Partner of CCV Capital, Former Managing Partner of KPCB China, was invited to attend the forum and participated in a roundtable discussion themed “Business Development,” sharing insightful perspectives and forward-thinking views on the topic of “Cross-border Innovation and Venture Capital.”

Wei Zhou has long focused on early-stage investments in intelligent technologies, sustainability, globalization, and cutting-edge global technologies, especially demonstrating extensive experience and unique insights in artificial intelligence and innovative technologies. During the forum, he emphasized the pivotal role of AI technologies in driving cross-border innovation, stating:

“Deepseek has sounded a global alarm, demonstrating a groundbreaking approach to large models, while Manus has set a global benchmark for application developers, illustrating how applications should be built. Both have offered enlightening revelations, albeit at different layers—the foundational and the application layers.”

He further highlighted:

“It’s no longer appropriate to evaluate application-layer products by foundational-layer standards. Without robust application-layer support, foundational technologies risk becoming self-indulgent. Only by truly moving towards practical applications can AI deliver universal value.”

Wei Zhou’s insights not only provide fresh perspectives for the future development of AI technologies but also inject practical inspiration into cross-border innovation and global collaboration.

Discussing the significant structural changes in the venture capital industry over the past eighteen months, Wei Zhou noted:

“The venture capital landscape has undergone dramatic structural shifts in the past two years. Silicon Valley’s VC industry has become fiercely competitive, leading to significant turnover and a notable decline in fundraising. However, AI has emerged as a standout growth area and a focal point for global investments.”

To entrepreneurs navigating these changes, Wei Zhou offered three key recommendations:

“First, maintain the advantage of rapid iteration and continuous improvement. Second, entrepreneurs should strategically align their ventures with large enterprises, as major corporations will consistently acquire innovative startups to keep pace with AI advancements. Third, entrepreneurs should target global markets, particularly emerging regions with less competition, such as Mexico, where abundant opportunities exist.”

At the conclusion of the roundtable, Wei Zhou also shared valuable advice for aspiring young venture capitalists:

“First, venture capital is inherently social; building extensive networks and relationships is essential for accessing high-quality investment opportunities. Second, successful VC practitioners must possess sharp insights into future trends and quickly identify market sparks. Individuals who rely solely on cautious, analytical approaches may find this dynamic and rapidly evolving field unsuitable.”

The Harvard College China Forum, organized entirely by students, is the largest and longest-running China-focused summit globally. Under the theme “Navigating Changing Times,” this year’s forum aimed to foster dialogue among leaders and thought pioneers across political, business, and academic circles from both China and the United States, exploring opportunities and building consensus for mutually beneficial long-term cooperation.

During the forum, prominent figures from the business, political, and academic communities worldwide gathered to engage in in-depth discussions on frontier topics such as international relations, economics, biotechnology, and artificial intelligence. Distinguished guests included Kevin Rudd, former Prime Minister of Australia; Xavier R. Rolet, former CEO of the London Stock Exchange Group; Alexis Tsipras, former Prime Minister of Greece; Hu Wei, President of Bank of China USA and Chairman of the China General Chamber of Commerce-USA; and George Church, Professor of Genetics at Harvard University and Member of the U.S. National Academy of Sciences.

Established in 1997, the Harvard College China Forum is devoted to building bridges between China and the world, exploring the role and contributions of Chinese enterprises within the global context. In their opening speeches on April 5th, several guests highly praised the stabilizing role of China’s economy in the global market, Chinese enterprises’ commitment to developing new productivity paradigms, and the promising prospects of China’s vast market.

CK Life Sciences Files Patent Applications for Circular mRNA TROP2 Cancer Vaccine

Breast Cancer Animal Studies Show Unprecedented Anti-Cancer Efficacy of 100% Tumor Growth Inhibition


HONG KONG SAR – Media OutReach Newswire – 11 April 2025 – CK Life Sciences Int’l., (Holdings) Inc. (“CK Life Sciences”), a leader in cancer vaccine development, announces the latest progress in its pharmaceutical R&D, namely the filing of an Original Grant Patent application in Hong Kong and a provisional patent application in the United States for novel cancer vaccines targeting Trophoblast Cell Surface Antigen 2 (“TROP2”).

TROP2 is a cell surface glycoprotein that is overexpressed in a wide range of cancers, including breast, lung, pancreatic, and colorectal cancers. This protein plays a critical role in cell proliferation, migration, and invasion, and its overexpression is frequently linked to aggressive tumor behavior and poor clinical outcomes. Given its high expression in cancer cells and minimal presence in normal tissues, TROP2 has emerged as a promising therapeutic target in oncology.

TROP2-positive triple-negative breast cancer animal study demonstrated 100% tumor growth inhibition

TROP2 cancer vaccines covered by the patent application include innovative circular mRNA (circRNA) and fusion protein vaccine constructs that can induce robust T cell immune responses and have demonstrated impressive tumor growth inhibition in preclinical studies of triple-negative breast cancer and colorectal cancer. The results of animal studies involving triple-negative breast cancer (“TNBC”) have been encouraging, with mouse models showing 100% tumor growth inhibition after receiving the TROP2 cancer vaccine. Overall, 100% inhibition of tumor growth was achieved in four of the five studies when mice were treated with a TROP2 vaccine candidate, while the remaining study demonstrated approximately 80% tumor growth inhibition.

Triple-negative breast cancer disproportionately prevalent and aggressive among Asian women

The results of animal studies of the TROP2 cancer vaccines are of particular relevance to the Asian region. Breast cancer rates in Asia are rising sharply, with younger women widely affected. In particular, TNBC shows both higher prevalence and more aggressive behavior in Asian populations compared to Western counterparts. Additionally, TNBC has fewer treatment options and demonstrates significantly higher rates of metastasis and recurrence than other breast cancer subtypes.

Unprecedented anti-cancer efficacy

“TROP2 is an exciting therapeutic target and preclinical studies of our cancer vaccine in triple-negative breast cancer exhibited 100% inhibition of tumor growth, demonstrating unprecedented anti-cancer efficacy. We look forward to advancing our TROP2 cancer vaccine expeditiously into clinical trials to benefit patients and believe it holds significant potential in preventing cancer recurrence,” said Dr. Melvin Toh, Chief Scientific Officer at CK Life Sciences.

Data on the TROP2 cancer vaccines will be presented at upcoming cancer conferences. In recent years, CK Life Sciences has showcased its growing early-stage cancer vaccine pipeline through preclinical data presentations at leading oncology conferences, alongside the filing of multiple patents. Developed in its Hong Kong-based R&D laboratories, these innovative vaccines target a broad spectrum of tumor antigens, immune checkpoint proteins, and other key components within the tumor-immune microenvironment.

Hashtag: #CKLifeSciences #CancerVaccines #R&D #BreastCancer #PatentApplication #Pharmaceutical

The issuer is solely responsible for the content of this announcement.

About CK Life Sciences

CK Life Sciences Int’l., (Holdings) Inc. (stock code: 0775) is listed on the Stock Exchange of Hong Kong. With a mission of improving the quality of life, CK Life Sciences is engaged in healthcare research and development, with operating businesses that enable its R&D sustainability. Regarding pharmaceutical research and development, CK Life Sciences’ operations are focused on conducting research and development into cancer vaccines and pain management solutions. CK Life Sciences is a member of the CK Hutchison Group. For additional information, please visit .